| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 4, 2026 | Huaguan Biotechnology | $14.4M Series C | — | Changjiang Capital, Changzhou Qihang Synthetic Biology Venture Capital Fund, Shunxi Fund, Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise |